Anne Li Feburary 25th, 2017
This week, Cancer Research UK's News Digest gives us updates on genome editing technology, legal case over who ‘owns’ the CRISPR technology, brain tumours, tamoxifen, Scottish radiology services, people in Wales, calculating patients’ personal risk of cancer, why cancer rates are rising faster in women than in men, oesophageal or upper stomach cancer, UK households spent less on cigarettes and alcohol in the last year, and finally……. ‘manageable’ pancreatic cancer? This week's number is 63, which is the percentage of GPs who said in Cancer Research's survey that they would like a second opinion before prescribing tamoxifen for women at high risk of breast cancer.
See original article at: http://scienceblog.cancerresearchuk.org/2017/02/18/news-digest-landmark-week-for-crispr-genome-editing-cancer-preventing-drugs-lifetime-weight-andmanageable-pancreatic-cancer/